Physician profile
Charles E Mackel
NPI 1639664733
$1,632.86
in general payments reported to CMS, 2019-2025
9 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $330 · 2023: $545 · 2024: $229 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $630.19 | 2019-2020 | |
| Medtronic, INC. | $254.98 | 2023-2024 | Pipeline |
| Rapid Medical LTD | $164.09 | 2023 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Zimmer Biomet Holdings, INC. | $152.05 | 2023 | Neuro Plating System |
| Stryker Corporation | $147.21 | 2025 | Evolve |
| Penumbra, INC. | $107.60 | 2023 | Red 72 |
| Cordis US Corp. | $80.94 | 2025 | Angioguard, Precise Pro Rx |
| Imperative Care, INC | $77.52 | 2023-2024 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Microvention, INC. | $18.28 | 2023 | Azur Cx Detachable |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Mackel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.